Is SHPMY or QYLD a better dividend investment in 2026?

SHPMY currently yields 3.82% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: QYLD offers higher current income.

What is the dividend yield difference between SHPMY and QYLD?

SHPMY has a forward dividend yield of 3.82% ($0.29/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 8.10 percentage points.

Home › Compare › SHPMY vs QYLD

SHPMY vs QYLD: Dividend Comparison 2026

SHPMY yields 3.82% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SHPMY wins by $1408.62M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SHPMY

● Live price

3.82%

Share price

$7.60

Annual div

$0.29

5Y div CAGR

100%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1408.65M

Annual income

$1,341,128,296.97

Full SHPMY calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — SHPMY vs QYLD

📍 SHPMY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SHPMY	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SHPMY + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SHPMY pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SHPMY

Annual income on $10K today (after 15% tax)

$324.34/yr

After 10yr DRIP, annual income (after tax)

$1,139,959,052.42/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, SHPMY beats the other by $1,139,954,242.01/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SHPMY + QYLD for your $10,000?

SHPMY: 50%QYLD: 50%

100% QYLD50/50100% SHPMY

Portfolio after 10yr

$704.34M

Annual income

$670,566,978.15/yr

Blended yield

95.21%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SHPMY buys

QYLD buys

No recent congressional trades found for SHPMY or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSHPMYQYLD

Forward yield	3.82%	11.92% ✓
Annual dividend / share	$0.29	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	100% ✓	0%
Portfolio after 10y	$1408.65M ✓	$25.4K
Annual income after 10y	$1,341,128,296.97 ✓	$5,659.31
Total dividends collected	$1403.79M ✓	$27.1K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: SHPMY vs QYLD ($10,000, DRIP)

Year	SHPMY Portfolio	SHPMY Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$11,463	$763.16	$10,352	$1,192.36	+$1.1K → SHPMY
2	$13,901	$1,635.18	$10,830	$1,347.57	+$3.1K → SHPMY
3	$18,580	$3,706.34	$11,460	$1,539.07	+$7.1K → SHPMY
4	$29,141	$9,259.81	$12,275	$1,777.84	+$16.9K → SHPMY
5	$58,326	$27,145.47	$13,323	$2,078.95	+$45.0K → SHPMY
6	$163,965	$101,556.29	$14,667	$2,463.34	+$149.3K → SHPMY
7	$709,076	$533,633.18	$16,396	$2,960.57	+$692.7K → SHPMY
8	$5,072,218	$4,313,507.31	$18,631	$3,612.97	+$5.05M → SHPMY
9	$63,101,541	$57,674,267.04	$21,548	$4,482.15	+$63.08M → SHPMY
10	$1,408,646,945	$1,341,128,296.97	$25,398	$5,659.31	+$1408.62M → SHPMY

SHPMY vs QYLD: Complete Analysis 2026

SHPMY — Stock

Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.

Full SHPMY Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this SHPMY vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SHPMY vs SCHD SHPMY vs JEPI SHPMY vs O SHPMY vs KO SHPMY vs MAIN SHPMY vs XYLD SHPMY vs JEPQ SHPMY vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.